Elliott Takes Large Position in Bio-Rad, Seeks Operational Overhaul
Elliott Investment Management has amassed a sizeable stake in Bio-Rad Laboratories (BIO) and is expected to press for operational changes aimed at lifting the company’s lagging share performance. The stake comes as Bio-Rad faces revenue challenges after a COVID-related windfall faded, pressure from a lower-valued holding in Sartorius (SATG), and so…